JPMORGAN CHASE & CO - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 83 filers reported holding LEAP THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$1,000
+99900.0%
3,374
+48.1%
0.00%
Q4 2022$1
-100.0%
2,278
-63.2%
0.00%
Q3 2022$5,0000.0%6,190
+48.9%
0.00%
Q2 2022$5,000
-72.2%
4,156
-60.6%
0.00%
Q1 2022$18,000
-28.0%
10,542
+35.4%
0.00%
Q4 2021$25,000
-72.8%
7,786
-80.9%
0.00%
Q4 2020$92,00040,862
+272313.3%
0.00%
Q3 2020$0
-100.0%
15
-100.0%
0.00%
Q2 2020$1,148,000
+934.2%
549,184
+3752.3%
0.00%
Q3 2018$111,000
-67.0%
14,256
-64.8%
0.00%
Q1 2018$336,000
+33500.0%
40,503
+39223.3%
0.00%
Q4 2017$1,0001030.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Perceptive Advisors 16,952,992$27,802,0000.18%
Opaleye Management Inc. 540,000$886,0000.15%
ACT CAPITAL MANAGEMENT, LLC 134,000$220,0000.11%
Artal Group S.A. 3,000,000$4,920,0000.10%
HHLR ADVISORS, LTD. 3,575,745$5,864,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 910,047$1,492,0000.04%
PERSONAL CFO SOLUTIONS, LLC 78,165$128,0000.03%
GSA CAPITAL PARTNERS LLP 122,401$201,0000.02%
Windsor Creek Advisors, LLC 46,955$77,0000.02%
Golden Green, Inc. 14,824$24,0000.02%
View complete list of LEAP THERAPEUTICS INC shareholders